pf-05089771
Small moleculeexperimental
Clinical trial activity
13 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
10
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT01165736)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
Nc1[nH]ncc1-c1cc(Cl)ccc1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl- Mol. weight
- 500.36 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545171 ↗
- ChEMBLCHEMBL2325014 ↗
Also known as
- pf-05089771
- pf-05089771
- pf-05089771
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02349607 | Phase 1 | Jan 1, 2015 | Pfizer |
| NCT02215252 | Phase 2 | Nov 10, 2014 | Pfizer |
| NCT01934569 | Phase 1 | Sep 1, 2013 | Pfizer |
| NCT01854996 | Phase 1 | May 1, 2013 | Pfizer |
| NCT01772264 | Phase 1 | Jan 1, 2013 | Pfizer |
| NCT01769274 | Phase 2 | Oct 1, 2012 | Pfizer |
| NCT01690351 | Phase 1 | Sep 1, 2012 | Pfizer |
| NCT01563497 | Phase 1 | Feb 1, 2012 | Pfizer |
| NCT01529671 | Phase 1 | Jan 1, 2012 | Pfizer |
| NCT01529346 | Phase 2 | Dec 1, 2011 | Pfizer |
| NCT01365637 | Phase 1 | Jun 1, 2011 | Pfizer |
| NCT01259882 | Phase 1 | Dec 1, 2010 | Pfizer |
| NCT01165736 | Phase 1 | Jul 1, 2010 | Pfizer |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 13 | 13 | 2 | 2010 |
1 organizations
Page 1 / 1